One Health Group

Delivering noncontact biometric information - anywhere, anytime


Private Fundraise

This company may be interested in raising funds from accredited investors. You must Request Access to see more information about this company.

Request Access 9

The medical innovators, pioneers and geniuses behind One Health Group (OHG) were saddened by the preventable human and animal illnesses afflicting so many. This is often attributable to a lack of readily available biometrics. To put an end to this once and for all, OHG developed a patented mobile health assessment platform that uses intelligent sensors and artificial intelligence to provide personalized, context-based health information - anywhere and at anytime. We do this by integrating human, animal and environmental data, which are intrinsically linked.

For both human and animal clinicians, it's virtually impossible to:

For Clinical Research Organizations, it's virtually impossible to:

OHG solves these problems by offering a noncontact
intelligent sensor platform that is:

Initially leading with our noncontact intelligent animal sensor platform which can collect:

  • Clinically-actionable activity
  • Behavior
  • Contextual biometric data - anywhere and at anytime, with an initial focus on cardiopulmonary applications

Data collection is possible without the need for a trained technician or clinician.

Our platform then stores and transmits that data to a mobile application and/or cloud for:

  • Visualization
  • Further analysis
  • Alerting
  • Clinical review
  • Taking action
  • Predictive Analytics


The foundation of OHG's comprehensive solution is Ultra-WideBand (UWB) radar.
This is combined with other sensors to:

  • Collect
  • Analyze
  • And present context-based biometrics:
    ○ Anatomical
    ○ Functional
    ○ Physiological

The solution includes:

Our solution provides for over-the-air upgrades and modifications for the Company to be able to seamlessly push updates.

And - more importantly - for the professional to be able to push new Careflow configurations to the health sensor.

This changes the collection regimen of health and wellness data, including associated alert thresholds.

OHG has developed, manufactured, and fielded (for clinical studies)
three versions of the animal health monitor, cloud, and analytics.

We have designed a mobile app, which will be fielded in our fourth version.
OHG has selected MIDI Product Development to be its development partner.

  • 71 issued patents (including 12 licensed patents -- exclusive, worldwide, perpetual licenses)
  • 42 pending patents

Ankara University Convergent Medical Technologies  |  Cornell University  | IBM Federal Systems Johns Hopkins University | Memorial University of Newfoundland | Ruhr University | Swineburne University | Texas A&M | University of Naples Federico II | University of Pennsylvania |

Albert Di Rienzo | President and Chief Innovation Officer

  • 35 Years Medical R&D
  • Award-Winning Executive and Serial Entrepreneur
  • Medical Technology Mentor
  • Commercialized more than 100 Medical Solutions
  • Former Professor of Forensic Science, with a focus on CBRN (Chemical, Biological, Radiological, Nuclear) forensics
  • Degreed in computer science, with a focus on artificial intelligence
  • 1 of 13 appointed to the inaugural National Biodefense Science Board under both the Bush and Obama Administrations

Dave Eilers | Vice President of Business Development

  • 25 Years Executive Leadership
  • AHA/Design Thinking Expert
  • Launch NY Seed Fund
  • NSF I-Corps Industry Mentor
  • MBA Faculty/Entrepreneurship
  • 30 Years of BD and MarComm

The Business Plan area is locked. You must Request Access to this company to see more information including the Business Plan.

Request Access


No updates yet.


No backers yet.

Quick Signup TBD

You must have an account to do this!

the platform

Copyright © 2019 All rights reserved.

Fundable is a software as a service crowdfunding platform. Fundable is not a registered broker-dealer and does not offer investment advice or advise on the raising of capital through securities offerings. Fundable does not recommend or otherwise suggest that any investor make an investment in a particular company, or that any company offer securities to a particular investor. Fundable takes no part in the negotiation or execution of transactions for the purchase or sale of securities, and at no time has possession of funds or securities. No securities transactions are executed or negotiated on or through the Fundable platform. Fundable receives no compensation in connection with the purchase or sale of securities.